Duxbury MS - Search Results

1

CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.

Duxbury MS, Matros E, Clancy T, Bailey G, Doff M, Zinner MJ, Ashley SW, Maitra A, Redston M, Whang EE. Duxbury MS, et al. Ann Surg. 2005 Mar;241(3):491-6. doi: 10.1097/01.sla.0000154455.86404.e9. Ann Surg. 2005. PMID: 15729073 Free PMC article.

2

Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine.

Ramsanahie A, Duxbury MS, Grikscheit TC, Perez A, Rhoads DB, Gardner-Thorpe J, Ogilvie J, Ashley SW, Vacanti JP, Whang EE. Ramsanahie A, et al. Among authors: duxbury ms. Am J Physiol Gastrointest Liver Physiol. 2003 Dec;285(6):G1345-52. doi: 10.1152/ajpgi.00374.2002. Epub 2003 Aug 14. Am J Physiol Gastrointest Liver Physiol. 2003. PMID: 12919941 Free article.

3

Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness.

Duxbury MS, Waseem T, Ito H, Robinson MK, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Biochem Biophys Res Commun. 2003 Sep 19;309(2):464-8. doi: 10.1016/j.bbrc.2003.08.024. Biochem Biophys Res Commun. 2003. PMID: 12951072

4

RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity.

Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Biochem Biophys Res Commun. 2003 Nov 21;311(3):786-92. doi: 10.1016/j.bbrc.2003.10.060. Biochem Biophys Res Commun. 2003. PMID: 14623342

5

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Oncogene. 2004 Feb 26;23(8):1539-48. doi: 10.1038/sj.onc.1207272. Oncogene. 2004. Retraction in: Oncogene. 2023 Mar;42(14):1157. doi: 10.1038/s41388-023-02627-4 PMID: 14661056 Retracted.

6

Inhibition of pancreatic adenocarcinoma cellular invasiveness by blebbistatin: a novel myosin II inhibitor.

Duxbury MS, Ashley SW, Whang EE. Duxbury MS, et al. Biochem Biophys Res Commun. 2004 Jan 23;313(4):992-7. doi: 10.1016/j.bbrc.2003.12.031. Biochem Biophys Res Commun. 2004. PMID: 14706640

7

CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Oncogene. 2004 Jan 15;23(2):465-73. doi: 10.1038/sj.onc.1207036. Oncogene. 2004. Retraction in: Oncogene. 2023 Mar;42(12):939. doi: 10.1038/s41388-023-02625-6 PMID: 14724575 Retracted.

8

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Oncogene. 2004 Feb 19;23(7):1448-56. doi: 10.1038/sj.onc.1207247. Oncogene. 2004. Retraction in: Oncogene. 2023 Mar;42(12):938. doi: 10.1038/s41388-023-02626-5 PMID: 14973554 Retracted.

9

RNA interference: a practical approach.

Duxbury MS, Whang EE. Duxbury MS, et al. J Surg Res. 2004 Apr;117(2):339-44. doi: 10.1016/j.jss.2003.09.010. J Surg Res. 2004. PMID: 15047140 Review.

10

c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.

Duxbury MS, Ito H, Ashley SW, Whang EE. Duxbury MS, et al. Biochem Biophys Res Commun. 2004 Apr 23;317(1):133-41. doi: 10.1016/j.bbrc.2004.03.018. Biochem Biophys Res Commun. 2004. PMID: 15047158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters